INVESTMENT IN IMAGION BIOSYSTEMS

6 Months Ended

Jun. 30, 2022

INVESTMENT IN IMAGION BIOSYSTEMS

NOTE 3 - INVESTMENT IN IMAGION BIOSYSTEMS

NOTE 3 – INVESTMENT IN IMAGION BIOSYSTEMS

As of June 30, 2022, the Company owns 51,766,508 shares of Imagion, resulting in a noncontrolling interest of Imagion’s issued and outstanding common stock. Based upon Imagion’s trading price on June 30, 2022, approximately $0.02 per share, the fair value of the Imagion shares was approximately $960,000. During the six months ended June 30, 2022, the Company recorded a loss on fair value in its investment of $1,913,000.

Below is reconciliation for the changes to the investment in Imagion for the six months ended June 30, 2022:

Balance as of December 31, 2021	$	2,901,000
Change due to the sale of securities		(28,000	)
Change in the unrealized fair value of securities		(1,913,000	)
Balance as of June 30, 2022	$	960,000